Category: 3. Business

Spring Savings: For a limited time, get your first seasonal GQ Box for 50% off ($59 $29.50)—or take $30 off an annual subscription—using code DEAL.

---

From cutting-edge Swedish tech to Italian barbershop staples, the GQ Spring 2026 Box is packed with warm-weather essentials that’ll upgrade your routine without overcomplicating it. (No matter the season, it’s worth noting, looking sharp tends to start with getting the fundamentals right.)

As per usual, the latest edition of the Box delivers exactly what the season demands—and plenty of goods you’ll be downright thrilled to have on hand when the weather turns. Inside, you’ll find noise-cancelling earbuds, a grip of grooming hacks for your annual spring glow-up, a sleek tumbler, and more on-the-go gear expressly engineered for sunnier days.

If you don’t know already, the “GQ-endorsed products at one hell of a deal” is kind of the whole point of the Box. Every day, we test the latest and greatest in clothing, gear, tech, and grooming. When something really makes us smile, we share it with our Box subscribers. They get a Box—literally, a box!—of GQ-selected products shipped directly to their door.

---

New Member Gift: Gaston Luga Spläsh Hip Pack in Black

We recently published 13 Stocks Jim Cramer Talked About.  Advanced Micro Devices Inc. (NASDAQ:AMD) is one of the stocks that Jim Cramer talked about.

Advanced Micro Devices Inc. (NASDAQ:AMD) designs and sells chips used for gaming, personal computing, AI, and other applications. Its shares are up by 83% over the past year but down by 7% year-to-date. Goldman Sachs discussed the shares in February. The bank kept a Neutral rating and a $210 share price target on Advanced Micro Devices Inc. (NASDAQ:AMD)’s shares. Goldman discussed the firm’s latest earnings report and noted that while revenue and guidance were strong, the chip designer’s operating expenses were worrisome. Advanced Micro Devices Inc. (NASDAQ:AMD)’s shares had dipped by a stunning 17% following the firm’s fourth quarter earnings report. UBS lowered the share price target in February to $310 from $330. It kept a Buy rating on the stock and added that the future for the firm was uncertain, given its $1 billion gaming cut. Cramer discussed Advanced Micro Devices Inc. (NASDAQ:AMD)’s share price performance following the earnings:

“Well AMD was down way too much. I spoke to Lisa, it was not that bad, I think that she was very under promised so she could over deliver at the end of the year. But she felt she gave a good acquittal of herself.”

While we acknowledge the potential of AMD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

GDS Holdings Limited (NASDAQ:GDS) is one of the 12 best mid cap AI stocks to buy according to hedge funds. According to a report released on February 5, J.P. Morgan analyst Gokul Hariharan raised the firm’s price target on GDS Holdings Limited (NASDAQ:GDS) from $40 to $55 while maintaining a Buy rating. The firm’s upwardly adjusted price target suggests a further 18% upside from current levels. This upside is consistent with the Wall Street analysts’ median upside estimate of 11% based on 19 analysts covering the stock.

Ahead of the analyst’s recent price target increase, GDS Holdings Limited (NASDAQ:GDS) issued a capital markets update that drew investor attention. The company revealed on February 6 that it had filed a Form 6-K with the U.S. Securities and Exchange Commission. The filing relates to the transaction documents associated with a $300 million private placement of convertible preferred shares issued to a Chinese institutional investor. By raising capital through convertible preferred equity, GDS Holdings Limited (NASDAQ:GDS) highlighted its ongoing capacity to attract capital from institutional investors. The additional capital is expected to enhance the company’s financial flexibility, supporting its day-to-day operations and growth plans. At the same time, the filing reflects GDS’s commitment to meeting regulatory standards in both the United States and Hong Kong.

GDS Holdings Limited (NASDAQ:GDS) is an operator and developer of data centers. The company is operating in the People’s Republic of China. It provides colocation, consulting, managed hosting, managed cloud, and server middleware services. The company serves large Internet companies, telecommunications carriers & IT service providers, multinational corporations,  cloud service providers, financial institutions, and the large domestic private sector.

While we acknowledge the potential of GDS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT:  Cathie Wood’s Stock Portfolio: Top 10 Stocks to Buy and 30 Most Fantastic Stocks Every Investor Should Pay Attention To.

Disclosure: None. This article is originally published at Insider Monkey.

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.

• Italian authorities have opened a new tax investigation into Amazon, conducting searches at the company’s Milan headquarters and at the homes of senior managers.

• The inquiry focuses on Amazon’s tax affairs in Italy and comes as the group’s European operations face increased regulatory attention.

• Amazon, listed as NasdaqGS:AMZN, has criticized the actions as aggressive and disproportionate, highlighting tensions between the company and Italian tax authorities.

For you as an investor, this sits against the backdrop of Amazon’s broad business mix, from its core ecommerce operations to cloud services and digital content. Regulatory and tax questions have become more frequent talking points for large global platforms, especially in Europe, where authorities have been reassessing how multinational groups are taxed.

Looking ahead, outcomes from this investigation could affect Amazon’s compliance approach, disclosure practices, and the way it manages operational risk in key overseas markets. It may also contribute to wider debates on multinational taxation, which can influence costs, capital allocation, and how investors assess regulatory risk around NasdaqGS:AMZN over time.

Stay updated on the most important news stories for Amazon.com by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Amazon.com.

Is Amazon.com’s balance sheet strong enough for future acquisitions? Dive into our detailed financial health analysis.

For you, the key question is how a fresh Italian tax probe could affect Amazon’s cost base and flexibility at a time when it is already committing large sums to AI and data center investment. The investigation reportedly focuses on whether Amazon’s EU unit should have declared more income in Italy between 2019 and 2024. If authorities ultimately claim back taxes, interest, or penalties, that would be a direct cost. More broadly, it signals that tax structuring for large digital groups in Europe is under close review, which can add legal expenses, management distraction, and potentially tighter rules on how profits are booked across borders.

• This news lines up with the narrative’s point that regulatory pressure is a real factor for Amazon, as tax scrutiny in Italy sits alongside other legal and policy questions around cloud and ecommerce.

• It could challenge the idea that efficiency gains from automation and international expansion simply drop to the bottom line, because incremental tax or compliance costs in Europe may offset some of those benefits.

• Intensified tax enforcement in individual markets like Italy may not be fully reflected in long term margin assumptions, particularly if more countries reassess how they treat profits from AWS and ecommerce operations.

Knowing what a company is worth starts with understanding its story. Check out one of the top narratives in the Simply Wall St Community for Amazon.com to help decide what it is worth to you.

• ⚠️ Additional tax assessments, interest, or fines in Italy could lift Amazon’s effective tax rate and weigh on cash flows at a time of very high capital spending.

• ⚠️ A precedent in Italy might encourage other European countries to reexamine Amazon’s local tax base, increasing regulatory, legal, and compliance complexity versus peers such as Alphabet and Microsoft.

• 🎁 Clarified tax treatment and eventual settlements can reduce uncertainty and allow investors to better assess long term earnings quality and cash conversion.

• 🎁 Amazon’s diversified earnings engines, including AWS and advertising, provide multiple levers to absorb regulatory and tax costs compared with more narrowly focused retailers.

From here, it is worth tracking a few things closely. First, any disclosure from Amazon or Italian authorities on the size and scope of the alleged underpaid taxes, as that will shape the potential financial hit and timeline. Second, whether similar questions are raised in other EU markets, which would point to a broader pattern rather than a one off issue. Third, management commentary on how regulatory and tax developments are factored into capital allocation, especially as Amazon commits around US$200b of capex in 2026. Together, these signals can help you judge whether regulatory risk is becoming a structural feature of the Amazon investment case or remains a contained, country specific issue.

To ensure you’re always in the loop on how the latest news impacts the investment narrative for Amazon.com, head to the community page for Amazon.com to never miss an update on the top community narratives.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AMZN.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

The Canadian government’s recent approval of the first gene-edited animal to enter the food system has reignited debates over whether foods produced using genetic engineering techniques should be labelled.

Gene-edited animals, including faster-growing fish, heat-tolerant cows and disease-resistant pigs, have already been approved in the United States, Japan and several countries in South America. These decisions, including Canada’s approval, were made with limited public awareness and input.

Advocacy groups such as the Canadian Biotechnology Action Network, political parties including the Bloc Québécois and organic pork producers are calling for mandatory labelling of gene-edited meat in Canada.

Public demand

Public opinion research indicates that many Canadians view labelling gene-edited foods as essential. Polling commissioned by the Canadian Health Food Association suggests many Canadians want greater transparency about the use of gene editing for food production.

Studies in the United States also suggest that consumer acceptance increases when the benefits of gene editing are clearly communicated.

Similarly, a survey commissioned by the company that developed Canada’s first approved gene-edited pig found that many Canadians would consider purchasing gene-edited pork if health and environmental benefits were delivered.

Why label gene-edited meat?

Food labelling serves multiple purposes: it provides information about a product’s ingredients and the production methods involved. Labels also play a democratic role by promoting transparency and accountability. This in turn allows consumers to make choices that reflect health considerations as well as their ethical, political and environmental values.

Debates over the labelling of gene-edited meat often hinge on tensions between ethical principles such as protection and autonomy. On the one hand, governments are tasked with protecting the food supply and ensuring food safety. On the other hand, individual consumers have the right to know how food is produced and to make choices accordingly.

Proponents of labelling argue that consumers have a fundamental right to know what’s in their food, how it was produced and what potential risks are involved.

With gene-edited meat, public concerns include health and safety risks, as well as environmental consequences, animal welfare, corporate control of the food system via patents and licensing and threats to food sovereignty.

For example, gene-edited animals could potentially be harmed by unintended consequences, including off-target side effects. It is imperative to ensure traceability in commercial settings with clear mechanisms to report on animal health and welfare.

By enhancing consumer choice, labelling can also foster market competition.

Opponents of labelling argue that gene-edited foods are scientifically proven to be safe and that labelling could mislead consumers into assuming there is a risk where none exists. They argue that labels can create fear and confusion, potentially undermining the adoption of breeding techniques that could enhance health, reduce environmental impacts and improve food security.

Labelling also has political consequences. Market-based approaches shift responsibility to individual consumers, which can foreclose other avenues for collective decision-making about how food systems should be governed.

Mandatory versus voluntary labelling

Canada currently doesn’t require the labelling of genetically modified (GMO) or gene-edited foods. Under the Food and Drugs Act, labelling is mandated only when a product poses a health or safety concern.

This is at odds with approaches elsewhere. For example, the U.S. National Bioengineered Food Disclosure Standard requires companies to label genetically engineered foods, while decisions about the labelling of gene-edited foods are made on a case-by-case basis.

In Canada, voluntary labelling is permitted provided it’s truthful and not misleading. The Canadian Standards Board, scheduled soon to cease operations due to budget cuts, provides guidance on voluntary labelling for genetically engineered foods. Notably, its definition of genetic engineering excludes both conventional breeding and gene editing.

The Canada organics sector relies on voluntary non-GMO food labelling. Similar to international organic standards, certified organic products in Canada prohibit the use of genetically engineered and gene-edited seeds, feed and food.

Following Health Canada’s approval of gene-edited pigs in January, organic pork producer duBreton introduced Canada’s first verified non-gene-edited and non-cloned meat label.

This proposed label was also a response to a now-paused federal proposal to exclude cloned animals from the definition of novel foods, a move that would allow cloned meat to enter the market without consumer or government notification.

A lack of public engagement

The labelling of gene-edited meat raises several questions. Food labels can support consumer autonomy and transparency, but labels are not good at conveying complicated information. Labels also privilege market forces for making collective decisions, instead of other democratic processes such as public deliberation and stringent regulation.

In a regulatory context that largely promotes biotechnology while offering few opportunities for meaningful public engagement, it remains unclear whether labelling is the most effective democratic approach to gene-edited meat in Canada.

As gene-edited animals potentially become more common in global food systems, the question is not just whether to label these products, but which political opportunities labelling creates or restricts — and for whose benefit.

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

Hamilton Lane (HLNE) is back on investor radars after a mixed stretch in the share price, with recent returns over the month, past 3 months and year pulling back from earlier multi year gains.

See our latest analysis for Hamilton Lane.

At the latest share price of $122.76, Hamilton Lane’s recent 30 day share price return of a 19.65% decline and 1 year total shareholder return of a 20.21% decline point to fading momentum after stronger multi year gains, which may reflect shifting expectations around growth and risk.

If this pullback has you comparing options, it could be a suitable moment to broaden your search and check out 23 top founder-led companies as potential fresh ideas beyond Hamilton Lane.

With Hamilton Lane trading at $122.76 alongside an indicated intrinsic discount of about 33%, the key question is whether this recent slump has opened up a genuine opportunity or if the market already reflects its future growth.

Hamilton Lane’s fair value in the most followed narrative sits at $181.14 versus the latest close at $122.76. This puts a sizable gap between the model and the market and sets up a valuation story built on growth, margins and cash flows discounted at 7.91%.

Healthy pipeline/backlog in customized separate accounts and perpetual fundraising strategies creates forward visibility into recurring revenue streams and earnings growth, while the high unrealized carry balance (~$1.3 billion) points to potential for strong incentive fee income as more favorable macro conditions enable exits and crystallization of performance fees.

Read the complete narrative.

Curious what sits behind that confidence in future earnings power? This narrative leans heavily on rising fee income, expanding margins and a premium earnings multiple. Want to see exactly how those pieces stack up against the current price and discount rate assumptions? The full story spells out the numbers that support that $181.14 fair value.

Result: Fair Value of $181.14 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, this hinges on fee growth and margins holding up. Heavier regulation or fee pressure could quickly challenge those earnings assumptions and the premium P/E embedded in the story.

Find out about the key risks to this Hamilton Lane narrative.

The earlier view leans on a fair value of $181.14 based on future cash flows and earnings power. On current numbers, though, Hamilton Lane trades on a P/E of 23.1x versus a peer average of 12.6x and a fair ratio of 19.2x, which points to a richer price and some valuation risk if sentiment cools.

That kind of gap can matter if growth or margins fall short of expectations, so the real question is whether you think the current premium is a fair reflection of quality or a stretch too far.

See what the numbers say about this price — find out in our valuation breakdown.

If you look at these numbers and reach a different conclusion, or simply prefer hands on research, you can build your own narrative in just a few minutes, Do it your way.

A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Hamilton Lane.

If Hamilton Lane has sharpened your focus, do not stop here. The screener can help you spot other opportunities that fit how you like to invest.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include HLNE.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Officials hope the longer holiday will boost consumption amid an economic slump that is weighing on people’s minds.

“The overall environment isn’t very good,” said Liu Zhenqiang, 38, who works in tech. “I have many friends around me who are currently unemployed. So if you have a job yourself, you really need to cherish it.”

For some, the somber mood was captured by a plush toy that went viral after a stitching mistake by a Chinese retailer created the “crying horse,” greeting the new year with a mournful frown.

In the grand Chinese tradition of Spring Festival wordplay, another unlikely mascot has also emerged: the “Harry Potter” character Draco Malfoy. Some households are decorating their doors with pictures of a smirking Malfoy — played by English actor Tom Felton — because of the auspicious Chinese translation of his character’s name, “ma er fu,” which contains the words for “horse” and “fortune.”

This year is not just the Year of the Horse but the Year of the Fire Horse, which in Chinese astrology is associated with intensity, decisive action and excitement — or chaos.

Letao Wang, a professional astrologer in Hong Kong, compared the fire horse to a sports car.

“I think the fire horse here, in a good way, is telling us that a lot of things are going to move forward,” he said.

“It’s about speed. It’s about momentum. It’s about fast movement,” Wang said. “But at the same time, we really have to know how to focus on the road, so to speak, and how to balance ourselves so that we are driving the horse instead of falling off it.”

Chinese companies are trying to seize on that momentum before the holiday even begins, with tech giants engaged in a “red envelope war” as they compete for users for their AI assistants.

Tencent and Baidu are giving away a combined 1.5 billion yuan ($217 million) in digital red envelopes, which are small cash gifts traditionally handed out for the new year. Alibaba is spending 3 billion yuan ($431 million) on a discounted boba tea promotion for its Qwen chatbot that generated 10 million orders in the first nine hours, overwhelming shops and delivery riders and crashing servers.

A year after Chinese start-up DeepSeek rattled the global tech industry with the Spring Festival release of its low-cost AI model, new models are also expected from DeepSeek and others. They include Seedance 2.0, an AI video generator from TikTok owner ByteDance that was released Monday.

Though China has changed greatly in recent decades — with special foods and new outfits that were once rare holiday treats now everyday purchases for many middle-class people — Xu said some aspects of the new year celebration have stayed the same.

“We still kowtow to our elders and give New Year greetings; those traditions remain,” he said. “We also have a set menu for what to eat each day.”

“And we still buy new clothes — no matter what, everyone in the family puts on new clothes on the first day of the Lunar New Year.”

Liu Fang, an office clerk from Shandong province, said he thought 2026 “might be better than before,” despite the tough economy.

“Even though robots are replacing some labor, new industries and job openings will emerge,” he said.

“Ultimately, it comes down to hard work and personal ability.”

Janis Mackey Frayer, Dawn Liu and Erin Tan reported from Beijing, and Jennifer Jett reported from Hong Kong.

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

Kanematsu (TSE:8020) has drawn fresh attention after a 2.3% decline over the last day, following a strong past 3 months where the share price return stands at 36.2%.

Over the past month, the stock is up 11.2%, while the 1 year total return is 85.5%. That backdrop gives investors some recent context before weighing Kanematsu’s current earnings profile and valuation.

See our latest analysis for Kanematsu.

For Kanematsu, the recent 2.3% one day share price decline comes after a strong run. Momentum remains positive given the 30 day share price return of 11.2% and the 1 year total shareholder return of 85.5%.

If Kanematsu’s gains have you rethinking where you hunt for opportunities, this could be a good moment to check out our screener of 11 top founder-led companies as potential next ideas.

With Kanematsu trading at ¥2,229.5 and sitting at a 7.5% intrinsic discount plus a 16.7% gap to analyst targets, you have to ask: is there still an opportunity here, or is future growth already priced in?

Kanematsu is trading on a P/E of 11.5x at a last close of ¥2,229.5, and current indicators suggest the shares are priced below several value markers in its peer group.

The P/E multiple simply compares the share price to earnings per share, so it is a quick way to see how the market is valuing each yen of profit. For a trading oriented group like Kanematsu, investors often watch this closely because earnings can be sensitive to economic cycles and sector conditions.

Here, the current P/E of 11.5x screens as good value in several ways. It sits below the estimated fair P/E of 15.7x that our fair ratio work points to as a reference level for the market, and it is also lower than the JP Trade Distributors industry average of 12x and the peer average of 12.6x. Taken together, those gaps indicate the market is paying less for Kanematsu’s earnings than for similar companies, even though the company has reported high quality earnings, 5 year annual earnings growth of 16.3% and 23.8% earnings growth over the last year that exceeded the wider Trade Distributors industry.

Explore the SWS fair ratio for Kanematsu

Result: Price-to-Earnings of 11.5x (UNDERVALUED)

However, you also have to weigh risks such as earnings sensitivity to economic cycles, as well as the broad mix of trading activities across multiple segments and regions.

Find out about the key risks to this Kanematsu narrative.

While the current 11.5x P/E hints at value, our DCF model also points to Kanematsu trading below its estimated cash flow value, with the share price at ¥2,229.5 versus a model value of ¥2,410.29. If both signals line up, it may be useful to consider how comfortable you are with the risks behind those cash flow assumptions.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Kanematsu for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 21 high quality undervalued stocks. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

If this take does not fully match your view, or you prefer building on your own research, you can shape a customised Kanematsu story in just a few minutes, starting with Do it your way

A great starting point for your Kanematsu research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.

If Kanematsu is only one piece of your watchlist, do not stop here. Use this moment to widen your search and pressure test your next moves.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include 8020.T.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Story Continues

Specialty

Please chooseI’m not a medical professional.Allergy and ImmunologyAnatomyAnesthesiologyBiostatisticsCardiac/Thoracic/Vascular SurgeryCardiologyCritical CareDentistryDermatologyDiabetes and EndocrinologyEmergency MedicineEpidemiology and Public HealthFamily MedicineForensic MedicineGastroenterologyGeneral PracticeGeneticsGeriatricsHealth PolicyHematologyHIV/AIDSHospital-based MedicineI’m not a medical professional.Infectious DiseaseIntegrative/Complementary MedicineInternal MedicineInternal Medicine-PediatricsMedical Education and SimulationMedical PhysicsMedical StudentNephrologyNeurological SurgeryNeurologyNuclear MedicineNutritionObstetrics and GynecologyOccupational HealthOncologyOphthalmologyOptometryOral MedicineOrthopaedicsOsteopathic MedicineOtolaryngologyPain ManagementPalliative CarePathologyPediatricsPediatric SurgeryPharmacologyPhysical Medicine and RehabilitationPlastic SurgeryPodiatryPreventive MedicinePsychiatryPsychologyPulmonologyRadiation OncologyRadiologyRheumatologySubstance Use and AddictionSurgeryTherapeuticsTraumaUrologyMiscellaneous